Optimal sequence-based design for multi-antigen HIV-1 vaccines using minimally distant antigens

Area of Science:

• Immunology
• Virology
• Vaccine Development

Background:

• Global human immunodeficiency virus type 1 (HIV-1) diversity presents a major challenge for vaccine development.
• Previous research linked infections with multiple founder variants to later development of neutralization breadth.

Purpose of the Study:

• To propose a novel vaccine design strategy for HIV-1.
• To integrate the variability of acute HIV-1 infections with multiple founder variants into a vaccine concept.

Main Methods:

• Developed a probabilistic model to simulate the diversity of multiple founder variants in acute HIV-1 infections.
• Applied the model to a subtype C consensus Envelope (Env) sequence.
• Generated a set of minimally distant Env sequences mimicking the mutational landscape of multi-founder infections.

Main Results:

• The simulated Env sequences accurately reflected the mutational landscape of multi-founder HIV-1 infections.
• The generated sequences included diversity at key antibody epitopes.
• The study produced a set of antigens representing minimal diversity from multiple founder variants.

Conclusions:

• The derived set of antigens can be used as a vaccine cocktail for specific HIV-1 subtypes or circulating recombinant forms.
• This vaccine strategy is expected to promote the development of broadly neutralizing antibodies against HIV-1.
• The approach addresses HIV-1 diversity to enhance vaccine efficacy.